Phenotypic Drug Screening: the Power of High Capacity Flow
Conference Recording Feb 06, 2013
About the Speaker
Manager, Assay Development Team, IntelliCyt Inc. Kim is a Ph.D. scientist with an established history of peer-reviewed, translational research and diversified biopharmaceutical industry experience including bioassay and reagent kit development, validation, commercialization, and competitive market research.
Multiplexed technologies are increasingly being incorporated into discovery programs evaluating the efficacy and toxicity of compounds. We will discuss a novel system for performing multiplex phenotypic screening assays on suspensions of cell or beads.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018